Americhem Expands Healthcare Footprint with China Investment

Got story updates? Submit your updates here. ›

Americhem, a leading specialty chemical company, has announced plans to expand its global healthcare footprint with a new investment in China. The expansion will be unveiled at the upcoming Chinaplas 2026 trade show, showcasing Americhem's commitment to serving the growing Chinese healthcare market.

Why it matters

Americhem's move to invest in China aligns with the country's rising demand for specialized healthcare materials and compounds. As one of the world's largest and fastest-growing healthcare markets, China presents a significant opportunity for Americhem to grow its global reach and better serve its customers in the region.

The details

The new investment will allow Americhem to increase its production capacity and technical capabilities in China, enabling the company to more efficiently supply healthcare customers in the region with its advanced polymer solutions and custom formulations. The expansion is part of Americhem's broader strategy to strengthen its global footprint and better support the evolving needs of the worldwide healthcare industry.

• Americhem will unveil the expansion plans at Chinaplas 2026, the leading plastics and rubber trade fair in Asia, taking place April 21-24, 2026.

What’s next

Americhem will showcase its expanded healthcare capabilities and new China investment at its booth during Chinaplas 2026, where the company will engage with existing and prospective customers in the region.